Literature DB >> 8030269

Enhancement of rotavirus immunogenicity by microencapsulation.

P A Offit1, C A Khoury, C A Moser, H F Clark, J E Kim, T J Speaker.   

Abstract

It was determined whether microencapsulation of rotavirus enhanced virus-specific immunity in mice. Combinations of several water-soluble anionic polymers and amines were tested for their capacity to form microcapsules which were stable in the presence of simulated gastric acid. Using the combinations of sodium alginate and spermine hydrochloride or sodium chondroitin sulfate and spermine hydrochloride we found that microcapsules (1) captured infectious rotavirus, (2) penetrated into the persisted in gut-associated lymphoid tissue (GALT) after oral inoculation, (3) delivered rotavirus antigen to GALT at levels greater than those detected after oral inoculation with free virus, and (4) enhanced the virus-specific humoral immune response after oral or parenteral immunization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030269     DOI: 10.1006/viro.1994.1463

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

Authors:  Yongsheng Ma; Jennifer C Pacan; Qi Wang; Yongping Xu; Xiaoqing Huang; Anton Korenevsky; Parviz M Sabour
Journal:  Appl Environ Microbiol       Date:  2008-05-30       Impact factor: 4.792

3.  Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice.

Authors:  C A Moser; T J Speaker; P A Offit
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates.

Authors:  S B Periwal; T J Speaker; J J Cebra
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.

Authors:  Teena Mohan; D Mitra; D N Rao
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 6.  Rotavirus infections: guidelines for treatment and prevention.

Authors:  U Desselberger
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.